1. Home
  2. PFSA vs BCG Comparison

PFSA vs BCG Comparison

Compare PFSA & BCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PFSA
  • BCG
  • Stock Information
  • Founded
  • PFSA 2009
  • BCG 2016
  • Country
  • PFSA United States
  • BCG United States
  • Employees
  • PFSA N/A
  • BCG N/A
  • Industry
  • PFSA Medical/Dental Instruments
  • BCG
  • Sector
  • PFSA Health Care
  • BCG
  • Exchange
  • PFSA Nasdaq
  • BCG Nasdaq
  • Market Cap
  • PFSA 25.1M
  • BCG 29.6M
  • IPO Year
  • PFSA N/A
  • BCG N/A
  • Fundamental
  • Price
  • PFSA $0.19
  • BCG $1.50
  • Analyst Decision
  • PFSA
  • BCG
  • Analyst Count
  • PFSA 0
  • BCG 0
  • Target Price
  • PFSA N/A
  • BCG N/A
  • AVG Volume (30 Days)
  • PFSA 15.7M
  • BCG 67.7K
  • Earning Date
  • PFSA 11-14-2025
  • BCG 11-13-2025
  • Dividend Yield
  • PFSA N/A
  • BCG N/A
  • EPS Growth
  • PFSA N/A
  • BCG N/A
  • EPS
  • PFSA N/A
  • BCG N/A
  • Revenue
  • PFSA $75,000.00
  • BCG $173,961,000.00
  • Revenue This Year
  • PFSA N/A
  • BCG N/A
  • Revenue Next Year
  • PFSA N/A
  • BCG N/A
  • P/E Ratio
  • PFSA N/A
  • BCG N/A
  • Revenue Growth
  • PFSA 7.14
  • BCG 7.45
  • 52 Week Low
  • PFSA $0.12
  • BCG $1.36
  • 52 Week High
  • PFSA $5.50
  • BCG $6.00
  • Technical
  • Relative Strength Index (RSI)
  • PFSA N/A
  • BCG 38.86
  • Support Level
  • PFSA N/A
  • BCG $1.41
  • Resistance Level
  • PFSA N/A
  • BCG $1.53
  • Average True Range (ATR)
  • PFSA 0.00
  • BCG 0.13
  • MACD
  • PFSA 0.00
  • BCG -0.03
  • Stochastic Oscillator
  • PFSA 0.00
  • BCG 12.11

About PFSA Profusa Inc.

Profusa Inc is a digital health technology company based in Emeryville, CA, that has developed a real-time, consumer-friendly platform that is designed to measure an individual's biochemistry, be easy to use, be cost-effective, and provide the necessary data to manage chronic disease and health and wellness decisions to improve health outcomes for a large population of potential users. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.

About BCG Binah Capital Group Inc. Common Stock

Binah Capital Group Inc formerly Wentworth Management Services LLC is a holding company that acquires and manages businesses in the wealth management industry. The company specializes in consolidating independent broker-dealers to capture economies of scale needed to service financial advisors in today's technology-enabled regulatory environment. Wentworth's core philosophy focuses on building long-term, productive relationships with its advisor base.

Share on Social Networks: